State Street SPDR S&P Pharmaceuticals ETF (XPH) Covered Calls
The SPDR S&P Pharmaceuticals ETF (XPH) is a passively managed exchange-traded fund that tracks the S&P Pharmaceuticals Select Industry Index. The fund provides exposure to U.S.-based companies in the pharmaceutical industry, including manufacturers of prescription and generic drugs.
You can sell covered calls on State Street SPDR S&P Pharmaceuticals ETF to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for XPH (prices last updated Mon 4:16 PM ET):
| State Street SPDR S&P Pharmaceuticals ETF (XPH) Stock Quote | ||||||
|---|---|---|---|---|---|---|
| Last | Change | Bid | Ask | Volume | P/E | Market Cap |
| 51.36 | -0.51 | 50.99 | 51.42 | 30K | - | 0.8 |
| Covered Calls For State Street SPDR S&P Pharmaceuticals ETF (XPH) | ||||||
|---|---|---|---|---|---|---|
| Expiration | Strike | Call Bid | Net Debit | Return If Flat |
Annualized Return If Flat |
|
| Apr 17 | 51 | 0.90 | 50.52 | 1.0% | 19.2% | |
| May 15 | 51 | 1.40 | 50.02 | 2.0% | 15.5% | |
| Subscribers get access to the full covered call chain, and more features. | ||||||
Want to make money with covered calls? Sign Up For A Free Trial
The SPDR S&P Pharmaceuticals ETF (XPH) offers targeted exposure to the pharmaceutical sector. It utilizes an equal-weighted approach, which gives smaller and mid-cap drug manufacturers a larger influence on fund performance compared to traditional market-cap-weighted indices. This structure makes XPH a "pure-play" instrument for capturing sector-specific performance, including industry-wide catalysts such as drug approvals, patent expirations, and regulatory changes.
Important Note on Options: XPH is functionally non-optionable. While exchange-listed options may technically appear in data feeds, the market suffers from a total lack of volume and open interest. Any attempt to use this ticker for covered calls, protective puts, or other derivative strategies will result in immediate and significant loss of capital due to prohibitive bid-ask spreads and slippage. This fund should be treated strictly as a buy-and-hold equity position for long-term sector exposure.
Competitive Landscape
Investors seeking liquid, optionable alternatives to express a view on the pharmaceutical or broader healthcare space—or to hedge sector risk—should utilize these industry-standard benchmarks:
- Health Care Select Sector SPDR Fund (XLV): The massive, highly liquid, and optionable benchmark for the entire U.S. healthcare sector; it is the standard for institutional and retail hedging of healthcare exposure.
- iShares Biotechnology ETF (IBB): A highly liquid, optionable alternative that focuses on the biotechnology segment, often paired with pharma ETFs to capture broader medical innovation.
- SPDR S&P Biotech ETF (XBI): An optionable, high-beta peer that offers deeper exposure to the innovative side of the industry, widely used for tactical sector-based options strategies.
Strategic Outlook
XPH’s strategic outlook is heavily influenced by the regulatory environment, drug pricing legislation, and the success of the pharmaceutical pipeline. Because it is an equal-weighted fund, it is less sensitive to the performance of a single mega-cap giant and more sensitive to the collective success of its constituent firms. It is best used as a long-term strategic satellite holding for investors looking to overweight the pharmaceutical industry.
| Top 10 Open Interest For Apr 17 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | SLV covered calls | 6. | QQQ covered calls | 1. | REPL covered calls | |
| 2. | EEM covered calls | 7. | GLD covered calls | 2. | BE covered calls | |
| 3. | NVDA covered calls | 8. | TLT covered calls | 3. | SGML covered calls | |
| 4. | KWEB covered calls | 9. | HYG covered calls | 4. | ONDS covered calls | |
| 5. | SPY covered calls | 10. | EWZ covered calls | 5. | NKE covered calls | |
Want more examples? XPEV Covered Calls | XPO Covered Calls
Risk Disclosure: Trading options involves significant risk and is not suitable for all investors. The information provided on this website is for educational and informational purposes only and does not constitute financial, investment, tax, or legal advice. Nothing contained on this site is an offer to buy or sell, or a solicitation of an offer to buy or sell, any securities or financial instruments.
Covered Call Strategy Risks: While covered call writing is often considered a conservative options strategy, it is not without risk. By selling a covered call, you are limiting your potential upside profit from the underlying stock. You remain exposed to the full downside risk of owning the underlying stock. In the event of a significant decline in the stock price, the premium received may not be sufficient to offset your losses.
No Guarantee of Performance: Past performance is not indicative of future results. Any examples, calculations, or hypothetical scenarios presented on this site are for illustrative purposes only and do not guarantee future returns or outcomes. Market conditions, liquidity, and trading system failures can affect your ability to execute trades at desired prices.
You should consult with a qualified professional advisor and conduct your own due diligence before making any investment decisions. By using this website, you acknowledge that you are responsible for your own investment decisions and agree to release this site and its affiliates from any liability relating to your use of this information. See the OCC's Characteristics and Risks of Standardized Options for more info.
